alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

Certification Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities andExchange Act of 1934

 

I, Hamsa Shadaksharappa, certify that:

1. I have reviewed this annual report on Form 10-K of IPALCO Enterprises, Inc. (the"registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport; 

3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant's other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;

(b) [Paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986]

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financialreporting that occurred during the registrant's fourth fiscal quarter that has materially affected,or is reasonably likely to materially affect, the registrant's internal control over financialreporting; and 

5. The registrant's other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant's auditors and the auditcommittee of registrant's board of directors (or persons performing the equivalentfunction):

(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant'sability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant's internal control over financial reporting.

Date:	March 11, 2004	
/s/ Hamsa Shadaksharappa	

Hamsa Shadaksharappa

Senior Vice President - Financial Services, Chief Financial Officer and Secretary
##### 



EXHIBIT 32
 COMM BANCORP, INC.
 CERTIFICATION PURSUANT TO  SECTION 1350
  1.
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company at the dates and for the periods
covered by the Report.
 Date:  March 14, 2007
    /s/ William F. Farber, Sr.William F. Farber, Sr.President and Chief Executive Officer  
 218




---



##### 



COMM BANCORP, INC.
 CERTIFICATION PURSUANT TO  SECTION 1350
  1.
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company at the dates and for the periods
covered by the Report.
 Date: March 14, 2007
    /s/ Scott A. SeasockScott A. SeasockExecutive Vice President and Chief
Financial Officer  
 219
**NUMBER 13-14-00295-CV**

**COURT OF APPEALS**

**THIRTEENTH DISTRICT OF TEXAS**

**CORPUS CHRISTI** – **EDINBURG**

****

**BOSTON FINANCIAL INSTITUTIONAL TAX CREDITS XII,**

**A LIMITED PARTNERSHIP AND SLP, INC.,				Appellants**

**v.**

**PASEO PLAZA APARTMENTS, L.P., BROWNSVILLE**

**HOUSING OPPORTUNITY CORPORATION AND**

**HOUSING AUTHORITY OF THE CITY OF BROWNSVILLE,	Appellees.**

****

**On Appeal from the 357th District Court**

**of Cameron County, Texas.**

****

**ORDER**

**Before Chief Justice Valdez and Justices Perkes and Longoria**

**Order Per Curiam**

	On June 2, 2014, appellants Boston Financial Institutional Tax Credits XII, a Limited Partnership, and SLP, Inc., filed an emergency motion to stay proceedings.  Through this motion, appellants seek to stay the trial court proceedings during the pendency of their accelerated interlocutory appeal of the trial court’s order denying appellants’ motion to compel arbitration.  

The Court, having examined and fully considered the emergency motion to stay proceedings, is of the opinion that it should be granted.  Accordingly, we GRANT appellants’ “Emergency Motion to Stay Proceeding” and order all trial court proceedings and discovery to be STAYED pending further order of this Court or final disposition of this appeal.  

IT IS SO ORDERED.

			PER CURIAM

Delivered and filed the

2nd day of June, 2014.

# image1.wmf

# oleObject1.bin
#### DUNN v. SPAHR.

Court of Appeals of Kentucky.

Oct. 16, 1953.

Charles E. Dunn, Covington, for appellant.

James C. Ware, Covington, for appellee.

CAMMACK, Justice.

This declaratory judgment proceeding was instituted to test the validity of a deed executed by Helen Spahr to Charles E. Dunn. In order to ascertain whether Helen Spahr had good title to the property, it is necessary that we look to the will of her mother, Bertha Spahr. The will follows :

“Newport, Ky.

July 7, 1947

It is my desire at my death, to pay $100 due my son Shirley, and $100 due my daughter Florence for painting the house,, and my daughter Helen $200.00 due her. Helen Lu my grand daughter $10.00. The rest of the money is to be given my husband, Lewis Spahr. I wish to be buried next to my father, and a place be prepared where our children are buried for Lew. Helen is to be buried, on the space on the corner of the lot on the side of her great grandmother.

/s/ Bertha Spahr.”

Bertha Spahr died in May, 1948, and’ her will was duly probated. At the time of her death Bertha Spahr’s estate consisted of a small bank account amountirlg to $38.13, two insurance policies amounting to $309.77, in addition to real estate which was encumbered to the extent of $1,141.56. Helen Spahr testified that she advanced $1,014.60 to pay the debts, including funeral expenses, and the specific legacies in the will. There was little difference in Bertha Spahr’s estate at the time she made her will and at the time of her death. After Bertha Spahr’s death, Lewis Spahr, the residuary beneficiary under the will, conveyed the real estate to himself and Helen Spahr with survivorship. Lewis Spahr died in July, 1948. Helen Spahr executed the. deed in question in August, 1952.

The question at hand is, Can the statement “The rest of the money is to be given my husband” be construed as meaning “the rest of my estate is to be given my husband?”' We think this interpretation does no violence to Bertha Spahr’s will when its provisions are considered in the light of the-facts and circumstances heretofore related. The cash and insurance were insufficient to-meet the debts and funeral expenses, and' the real estate was encumbered to the extent of some $1,100. Obviously, it would' have been necessary to sell the real estate to settle Bertha Spahr’s estate had not *633Lewis Spahr, the residuary legatee, and Helen Spahr, who had advanced the money to liquidate the estate, entered into the survivorship agreement. It is equally clear that Bertha Spahr intended to dispose of all of her estate. In the case of Mutual Life Insurance Company of New York v. Spohn, 172 Ky. 90, 188 S.W. 1078, it was pointed out that the word “money” is often used in wills in a very broad and elastic sense, and that when it is considered in the light of proper evidence is frequently given meaning to conform to the testamentary intent. See also, In re Ingham’s Estate, 315 Pa. 293, 172 A. 662, 93 A.L.R. 510; Page on Wills section 974. Any other interpretation would clearly defeat Bertha Spahr’s intent.

Judgment affirmed.
#### Ella STRONG, Appellant, v. The STATE of Texas, Appellee.

No. 28665.

Court of Criminal Appeals of Texas.

Dec. 12, 1956.

No attorney for appellant of record on appeal.

Leon Douglas, State’s Atty., Austin, for the State.

PER CURIAM.

Unlawfully carrying a pistol is the offense; the punishment, a fine of $400.

The record before us contains no statement of facts. The bill of exception appearing in the record can not be appraised in the absence of a statement of facts.

The judgment is affirmed.
[Federal Register Volume 89, Number 37 (Friday, February 23, 2024)]
[Notices]
[Pages 13744-13745]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03712]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1322]


Bulk Manufacturer of Controlled Substances Application: Siemens 
Healthcare Diagnostics Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics Inc. has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplementary Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 23, 2024. Such persons may also file a written request for a 
hearing on the application on or before April 23, 2024.

ADDRESSES: The Drug Enforcement Administration (DEA) requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 10, 2024, Siemens Healthcare Diagnostics 
Inc., 100 GBC Drive, Mailstop 108, Newark, Delaware 19702-2461 applied 
to be registered as a bulk manufacturer of the following basic 
class(es) of controlled substance(s):

[[Page 13745]]



------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Ecgonine................................    9180  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substance in 
bulk to be used in the manufacture of the DEA exempt products. No other 
activities for this drug code is authorized for this registration.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-03712 Filed 2-22-24; 8:45 am]
BILLING CODE P
Exhibit 99.1
                                                                  ------------


                      COUNTRYWIDE HOME LOANS SERVICING LP

                             OFFICERS' CERTIFICATE
                    ANNUAL STATEMENT OF THE MASTER SERVICER

                                  CWMBS, INC.
                  RESECURITIZATION PASS-THROUGH TRUST 2004-18
              MORTGAGE PASS-THROUGH CERTIFICATES, SERIES 2004-18

     The undersigned do hereby certify that they are each an officer of
Countrywide GP, Inc., general partner of Countrywide Home Loans Servicing LP
(a "Master Servicer"), and do hereby further certify pursuant to Section 3.16
of the Pooling and Servicing Agreement for the above-captioned Series (the
"Agreement") that:

(i) A review of the activities of the Master Servicer during the preceding
calendar year and of the performance of the Master Servicer under the
Agreement has been made under our supervision; and

(ii) To the best of our knowledge, based on such review, the Master Servicer
has fulfilled all its obligations under the Agreement throughout such year.

/s/ Craig Baingo                       Dated: March 29, 2006
------------------------

CRAIG BAINGO
EXECUTIVE VICE PRESIDENT


/s/ Kevin Meyers                       Dated: March 29, 2006
----------------

KEVIN MEYERS
MANAGING DIRECTOR, CHIEF FINANCIAL
OFFICER, LOAN ADMINISTRATION
**Exhibit 32.2**

****CERTIFICATION PURSUANT TO

18. U.S.C. SECTION1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the AnnualReport of Parkway Properties, Inc. (the "Company") on Form 10-K forthe annual period ended December 31, 2006 as filed with the Securities andExchange Commission on the date hereof (the "Report"), I, William R.Flatt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that, to myknowledge:

(1)       The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

(2)       The information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.

|  | /s/ William R. Flatt    |
|--|-------------------------|
|  | William R. Flatt (*)    |
|  | Chief Financial Officer |
|  | March 16, 2007          |

*A signed original of thiswritten statement required by Section 906 has been provided to ParkwayProperties, Inc. and will be retained by the Company and furnished to theSecurities and Exchange Commission or its staff upon request.
<PAGE>

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Lafayette Community Bancorp (the
"Company") on Form 10-QSB for the period ending June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Dennis
R. Hardwick, Chief Accounting Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.

/s/ DENNIS R. HARDWICK
----------------------
Dennis R. Hardwick
Chief Accounting Officer
August 13, 2002


The foregoing certification is being furnished solely pursuant to 18
U.S.C.ss.1350 and not for any other purpose, and is subject to the knowledge
standard contained in 18 U.S.C.ss.1350.
[Federal Register Volume 89, Number 41 (Thursday, February 29, 2024)]
[Notices]
[Page 14843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04211]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-OH-24-001, National Center 
for Construction Safety and Health Research and Translation.
    Dates and Times: May 13, 2024, 11 a.m.-6 p.m., EDT; and May 14, 
2024, 1 p.m.-6 p.m., EDT.
    Place: Video-Assisted Meeting.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Dan Hartley, Ed.D., Scientific 
Review Officer, Office of Extramural Programs, National Institute for 
Occupational Safety and Health, Centers for Disease Control and 
Prevention, 1095 Willowdale Road, Morgantown, West Virginia 26505. 
Telephone: (304) 285-5812; Email: <a href="/cdn-cgi/l/email-protection#e9ada1889b9d858c90a98a8d8ac78e869f"><span class="__cf_email__" data-cfemail="2d69654c5f594148546d4e494e034a425b">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04211 Filed 2-28-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### WILLIAMS v. STATE.

No. 26468.

Court of Criminal Appeals of Texas.

June 17, 1953.

M. D. Emerson, Paris, for appellant.

Wesley Dice, State’s Att-y., Austin, for the State.

DAVIDSON, Commissioner.

This is a conviction for violating the liqüo'r laws; the punishment, a fine of $150 and 90 days in jail.

Two questions are presented for review. These are: (a) the action of the court in permitting the.state to substitute the complaint upon, which the information was based, and (b) the failure of the court to quash the jury panel and array of jurors upon appellant’s motion.

It appears that the complaint was before the court at the time the case was called for trial. During the trial, the clerk of the court discovered that the complaint could not be found and apparently was lost. After conviction and after notice o-f appeal to this court, the state filed a motion' to substitute the lost complaint. After hearing, the ¿notion was granted and the complaint was duly substituted.

Appellant’s objection to this procedure appears to be founded upon the proposition that no complaint had, in fact, ever been filed and that therefore there was no lost complaint to be substituted.

The testimony of the clerk supports the trial court’s conclusion that the complaint had been lost.

The procedure substituting the lost complaint was expressly authorized by Art. 828, C.C.P. See, also, James v. State, 62 Tex.Cr.R. 610, 138 S.W. 408.

As to the failure o-f the court to quash the jury panel and array of jurors, the record before us reveals that Lamar County, where this case was tried, is under the jury wheel law. Arts. 2094 and 2095, V.A.C.S.

Appellant introduced much testimony tending to show that the provisions of the above statutes had not been complied with *176and that the jury panel for the week had not been drawn in accordance therewith. In view of the conclusion reached, a statement of these facts is not deemed called for.

We have made a search of the record before us and fail to find any evidence or certificate that the jury which tried appellant and rendered the verdict upon which the judgment here appealed from was based was selected from the jury panel which he claims was not properly drawn.

A defect in the drawing of the jury panel would be material only when the jury which tried appellant was selected therefrom. Gaytan v. State, 116 Tex.Cr.R. 215, 32 S.W.2d 361; Evans v. State, 110 Tex.Cr.R. 560, 9 S.W.2d 360.

We have no authority to presume that the jury which tried appellant was selected from the alleged irregular jury panel.

No reversible error appearing, the judgment is affirmed.

Opinion approved by the court.
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:



| | (1) | Registration Statements (Form S-8 Nos. 333-157168, 333-89140 and 33-62796) pertaining to the Second Amended and Restated 2001 Repligen Corporation Stock Plan, the 2001
Repligen Corporation Stock Option Plan, and the 1992 Repligen Corporation Stock Plan
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | Registration Statements (Form S-3 Nos. 333-106109, 333-30383, 333-57951, 333-76005, 333-79611, 333-95641, 333-31728, 333-35056 and 333-36280) of Repligen Corporation
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

of our reports dated June 10, 2010 with respect to the financial statements of Repligen Corporation and the effectiveness
of internal control over financial reporting of Repligen Corporation, included in this Annual Report (Form 10-K) for the year ended March 31, 2010.

/s/ Ernst & Young LLP

Boston, Massachusetts

June 10, 2010